Modulation of allergic airways disease employing bio-mimetic nanoparticles with TLR agonists.

Front Allergy · 2025 · PMC12426108 · PMID 40951841

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

These data suggest that certain formulations, partially modulate cytokine profiles in a manner consistent with dampened Th2 activity and enhanced Th1 responses, although changes beyond IL-4 did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.